Linda Christina Wilhelmine Freitag

Dr. Linda Christina Wilhelmine Freitag

AO Research Institute Davos, Davos, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2020 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
Keith ThompsonKeith Thompson
Keith Thompson
LFLinda Christina Wilhelmine Freitag
Linda Christina Wilhelmine Freitag
USUrsula Styger
Ursula Styger
KCKarin Camenisch
Karin Camenisch
SZStephan Zeiter
Stephan Zeiter
VSVincent A. Stadelmann
Vincent A. Stadelmann

21 December 2018 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
LFLinda Christina Wilhelmine Freitag
Linda Christina Wilhelmine Freitag
CGChristian Günther
Christian Günther
UEUrsula Eberli
Ursula Eberli
AFAnton Fürst
Anton Fürst
SZStephan Zeiter
Stephan Zeiter
VSVincent A. Stadelmann
Vincent A. Stadelmann

13 September 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
CSClaudia Siverino
Claudia Siverino
LFLinda Christina Wilhelmine Freitag
Linda Christina Wilhelmine Freitag
DADaniel Arens
Daniel Arens
USUrsula Styger
Ursula Styger
RRRobert Geoff Richards
Robert Geoff Richards
Keith ThompsonKeith Thompson
Keith Thompson
Total joint arthroplasty (TJA) surgeries are common orthopedic procedures, but bacterial infection remains a concern. The aim of this study was to assess interactions between wear particles (WPs) and immune cells in vitro and to investigate if WPs affect the severity, or response to antibiotic therapy, of a Staphylococcus epidermidis orthopedic device-related infection (ODRI) in a rodent model. Biofilms grown on WPs were challenged with rifampin and cefazolin (100 µg/mL) to determine antibiotic efficacy. Neutrophils or peripheral blood mononuclear cells (PBMCs) were incubated with or without S. epidermidis and WPs, and myeloperoxidase (MPO) and cytokine release were analyzed, respectively. In the ODRI rodent model, rats (n = 36) had a sterile or S. epidermidis-inoculated screw implanted in the presence or absence of WPs, and a subgroup was treated with antibiotics. Bone changes were monitored using microCT scanning. The presence of WPs decreased antibiotic efficacy against biofilm-resident bacteria and promoted MPO and pro-inflammatory cytokine production in vitro. WPs exacerbated osteolytic responses to S. epidermidis infection and markedly reduced antibiotic efficacy in vivo. Overall, this work shows that the presence of titanium WPs reduces antibiotic efficacy in vitro and in vivo, induces proinflammatory cytokine release, and exacerbates S. epidermidis-induced osteolysis.

1 April 2021 in Journal of Children's Orthopaedics
Verified
Journal Article
Open access
Jan BuschbaumJan Buschbaum
Jan Buschbaum
LFLinda Christina Wilhelmine Freitag
Linda Christina Wilhelmine Freitag
TSTheodor F. Slongo
Theodor F. Slongo
SZStephan Zeiter
Stephan Zeiter
MSMichael Schütz
Michael Schütz
MWMarkus Windolf
Markus Windolf
Purpose: Varus-valgus deformities in children and adolescents are often corrected by temporary hemi-epiphysiodesis, in which the physis is bridged by an implant to inhibit growth. With standard implant solutions, the acting forces cannot be regulated, rendering the correction difficult to control. Furthermore, the implant load steadily increases with ongoing growth potentially leading to implant-related failures. A novel implant concept was developed applying a controlled constant force to the physis, which carries the potential to avoid these complications. The study aim was to proof the concept in vivo by analyzing the effect of three distinct force levels on the creation of varus deformities. Methods: The proposed implant is made of a conventional cerclage wire and features a twisted coil that unwinds with growth resulting in an implant-specific constant force level. The proximal medial tibial physes of 18 lambs were treated with the implant and assigned to three groups distinct by the force level of the implant (200 N, 120 N, 60 N). Results: The treatment appeared safe without implant-related failures. Deformity creation was statistically different between the groups and yielded on average 10.6° (200 N), 4.8° (120 N) and 0.4° (60 N) over the treatment period. Modulation rates were 0.51°/mm (200 N), 0.23°/mm (120 N) and 0.05°/mm (60 N) and were constant throughout the treatment. Conclusion: By means of the constant force concept, controlled growth modulation appeared feasible in this preclinical experiment. However, clinical trials are necessary to confirm whether the results are translatable to the human pathological situation.